Press Releases
EC Grants Marketing Authorization for Gilead’s Vosevi for the Treatment of All Genotypes of Chronic Hepatitis C
Gilead Sciences, Inc announced that the European Commission has granted marketing authorization for Vosevi® (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg), as a once-daily single tablet regimen...
Clinical Trials
Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017
Clinical and laboratory personnel with the need to store vaccines, pharmaceuticals and other molecular or biological samples safely can benefit from a new series...
Press Releases
Teva Announces Launch of Generic Epiduo® in the United States
Teva Pharmaceutical Industries Ltd. announced the launch of generic Epiduo®1 (adapalene and benzoyl peroxide) gel, 0.1%/2.5% in the U.S. Adapalene and...
News
Eisai Submits Simultaneous Applications in The United States and Europe for Lenvatinib in Hepatocellular Carcinoma
Eisai Co., Ltd. announced that it has submitted applications to the US FDA and the EMA for its in-house discovered and developed anticancer agent...
Articles
Novel approaches to improved treatments for orphan genetic diseases: Enhanced intracellular delivery of protein therapy through natural transport mechanisms
Orphan genetic diseases have become an increasingly popular area for drug development through a variety of novel mechanistictherapeutic approaches.
The development of a means to...
Packaging & Labelling
Next Generation Thermal Transfer Overprinters Launched By Videojet To Meet Manufacturers Code Quality Needs
Manufacturers require high code accuracy and legibility from their Thermal Transfer Overprinters to improve production line efficiency and reduce overall costs. ...
News
Lack Of Confidence In Serialization Preparations Highlighted By New Research
More than one third (40 per cent) of pharmaceutical industry professionals are not confident that they will meet serialization deadlines in the US and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read